Good Laboratory Practice vs Good Clinical Practice

GLP and GCP are not interchangeable. The first governs preclinical laboratory work; the second governs clinical trials in human subjects. Knowing which standard a study followed is a first-line literacy skill.

Educational research-literacy content only. Not medical advice, not dosing guidance, not sourcing advice, and not a protocol for human or animal use. See our responsible information policy.

Good Laboratory Practice (GLP)

GLP is a quality system that governs non-clinical laboratory studies — especially the safety studies that support a medicine’s regulatory submission. GLP defines how laboratory studies should be planned, performed, monitored, recorded, and reported, with traceable documentation and an independent quality assurance function.

GLP applies to laboratory work. It does not define how a compound is used in humans, what dose is safe, or what an appropriate indication might be. A GLP-compliant rat study tells you the study itself is well-documented and traceable — not that the finding will translate to humans.

Good Clinical Practice (GCP)

GCP is the international quality standard for clinical trials in human subjects. It covers informed consent, protocol design, principal investigator responsibilities, monitoring, adverse event reporting, data integrity, and regulatory submission.

A GCP-compliant trial has been ethically reviewed, registered, and conducted with patient-safety safeguards. Studies done outside GCP — for example, self-experimentation, “biohacker” reports, or grey-market n=1 anecdotes — are not GCP and should not be treated as clinical evidence.

Why this distinction matters

When you encounter a claim that a peptide is “clinically proven” or “clinically studied,” ask:

• Was the study a GCP-compliant clinical trial in humans? If so, where is it registered?
• Or was it a preclinical (animal, in vitro) study — GLP or otherwise?
• Was it self-experimentation outside any oversight framework?

The word “clinical” is often stretched in marketing to cover any study at all. The distinction between preclinical and clinical is not a formality — it is the difference between mechanism plausibility and human-relevant evidence.

Why lab evidence is not clinical instruction

A well-designed rodent study can show that a compound has a measurable effect in a defined model. It cannot show that the effect occurs in humans, at any dose, with any acceptable safety margin. Translating lab evidence into clinical use is what clinical trials exist for — and is not a step that a website, a vendor, or a forum can shortcut.

See our companion explainer: animal vs human peptide research.